ASX
Neuren Pharmaceuticals
NEU:ASX•Healthcare
Sensitive ASX Announcement
Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025
Published: 07/05/26, 09:53am (AEST)•3 pages